top of page

Pipeline

Respiratory Syncytial Virus
(EuRSV)

EUPOP's lead candidate, currently in Phase 1 clinical studies in Korea, EuRSV, seeks to address the significant unmet medical need among pediatric and elderly populations for an effective vaccine against RSV

​

ClinicalTrials.gov

Picture3.png
Picture4.png

Herpes Zoster Virus
(EuHZV)

Shingles can be a serious condition, especially for older adults and people with weakened immune systems. EuHZV is currently undergoing Phase 1 evaluation.

​

ClinicalTrials.gov

Alzheimer's Disease

Azheimer's disease (AD) is the most prevalent neurodegenerative disorder in the world (47 million people affected)

_edited_edited.png

© 2023 EUPOP Life Sciences

bottom of page